Tenet Healthcare Files 8-K Report

TL;DR

THC filed an 8-K today, check for updates.

AI Summary

On August 5, 2024, Tenet Healthcare Corp. (THC) filed an 8-K report detailing a Regulation FD Disclosure and Other Events. The filing includes financial statements and exhibits, but specific financial figures or transaction details were not immediately available in the provided text.

Why It Matters

This filing indicates significant corporate events or disclosures by Tenet Healthcare, requiring investor attention.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report and does not inherently indicate negative news.

Key Players & Entities

• TENET HEALTHCARE CORP (company) — Registrant
• August 5, 2024 (date) — Date of Report
• Nevada (jurisdiction) — State of Incorporation
• 14201 Dallas Parkway (address) — Principal Executive Offices
• Dallas (location) — City of Principal Executive Offices
• Texas (location) — State of Principal Executive Offices
• 75254 (zip_code) — Zip Code of Principal Executive Offices

FAQ

Key Financial Figures

• $0.05 — nge on which registered Common stock, $0.05 par value THC New York Stock Exchange
• $910 million — Divested Facilities") for approximately $910 million in cash (after-tax proceeds of approxim
• $790 million — sh (after-tax proceeds of approximately $790 million). A copy of the press release is attach
• $12 million — nerated pre-tax income of approximately $12 million and Adjusted EBITDA less noncontrolling
• $60 million — oncontrolling interest of approximately $60 million , excluding interest expense of approxi
• $2 million — uding interest expense of approximately $2 million and depreciation and amortization expen
• $46 million — d amortization expense of approximately $46 million. The Company estimates recording a pre-
• $375 million — ng a pre-tax book gain of approximately $375 million as a result of this anticipated transac

Filing Documents

• thc-20240805.htm (8-K) — 37KB
• thc-20240805exh991.htm (EX-99.1) — 10KB
• tenethealthrgb.jpg (GRAPHIC) — 109KB
• 0000070318-24-000044.txt ( ) — 372KB
• thc-20240805.xsd (EX-101.SCH) — 2KB
• thc-20240805_def.xml (EX-101.DEF) — 17KB
• thc-20240805_lab.xml (EX-101.LAB) — 29KB
• thc-20240805_pre.xml (EX-101.PRE) — 18KB
• thc-20240805_htm.xml (XML) — 4KB

01

Item 7.01. Regulation FD Disclosure. On August 5, 2024, the Company issued a press release announcing the anticipated sale of our 70% ownership interest in five hospitals located in Alabama (Brookwood Baptist Medical Center, Citizens Baptist Medical Center, Walker Baptist Medical Center, Princeton Baptist Medical Center and Shelby Baptist Medical Center) and certain related operations (the "Divested Facilities") for approximately $910 million in cash (after-tax proceeds of approximately $790 million). A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference. For the twelve months ended June 30, 2024, the five hospitals and related operations included in the sale generated pre-tax income of approximately $12 million and Adjusted EBITDA less noncontrolling interest of approximately $60 million , excluding interest expense of approximately $2 million and depreciation and amortization expense of approximately $46 million. The Company estimates recording a pre-tax book gain of approximately $375 million as a result of this anticipated transaction. The Company also reaffirmed its Adjusted EBITDA outlook range for the year ending December 31, 2024 as disclosed in its earnings release dated July 24, 2024. The information contained in this Item 7.01 and Exhibit 99.1 is being furnished pursuant to Item 7.01 of Form 8-K. This information shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01

Item 8.01. Other Events. On August 5, 2024, the Company and certain of its subsidiaries announced entering into a definitive agreement (the "Sale Agreement") for the sale of our 70% ownership interest in five hospitals located in Alabama (Brookwood Baptist Medical Center, Citizens Baptist Medical Center, Walker Baptist Medical Center, Princeton Baptist Medical Center and Shelby Baptist Medical Center) and certain related operations to Orlando Health ("Purchaser"). Subject to the terms and conditions in the Sale Agreement, the Company has agreed to sell its ownership interest in the Divested Facilities for approximately $910 million in cash (subject to customary purchase price adjustments). As part of this transaction, Conifer Health Solutions will continue to provide revenue cycle management services through a new and expanded ten-year contract. The Transaction is not subject to a financing contingency. The Sale Agreement includes customary representations, warranties, covenants and termination provisions for each of the parties, as well as certain indemnities. The completion of the Transaction is subject to closing conditions, including but not limited to certain regulatory or governmental filings and approvals having been made or obtained, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. This transaction is anticipated to close in the fall of 2024. Cautionary Statement This report contains "forward-looking statements" - that is, statements that relate to future, not past, events. In this context, forward-looking statements often address the Company's expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "assume," "believe," "budget," "estimate," "forecast," "intend," "plan," "predict," "project," "seek," "see," "target," or "will." Forward-looking statements by their nature address m

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release issued on August 5, 2024. 104 Cover Page Interactive Data File (formatted as Inline XBRL) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TENET HEALTHCARE CORPORATION Date: August 5, 2024 By: /s/ T HOMAS A RNST Name: Thomas Arnst Title: Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR